A special issue dedicated to the 2022 meeting of the French society for nanomedicine
- 15 March 2024
- journal article
- editorial
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 654, 124006
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Evaluation of tumor growth remission in a murine model for subcutaneous solid tumors – Benefits of associating the antitumor agent crotamine with mesoporous nanosilica particles to achieve improved dosing frequency and efficacyInternational Journal of Pharmaceutics, 2023
- The use of liposomes functionalized with the NFL-TBS.40–63 peptide as a targeting agent to cross the in vitro blood–brain barrier and target glioblastoma cellsInternational Journal of Pharmaceutics, 2023
- The interplay between lysosome, protein corona and biological effects of cationic carbon dots: Role of surface charge titratabilityInternational Journal of Pharmaceutics, 2023
- Protein corona investigations of polyplexes with varying hydrophobicity – From method development to in vitro studiesInternational Journal of Pharmaceutics, 2023
- PLA-PEG forming worm-like nanoparticles despite unfavorable packing parameter: Formation mechanism, thermal stability and potential for cell internalizationInternational Journal of Pharmaceutics, 2023
- Diclofenac prodrugs nanoparticles: An alternative and efficient treatment for rheumatoid arthritis?International Journal of Pharmaceutics, 2023
- Shell-sheddable dendritic polyglycerol sulfates loaded with sunitinib for inhibition of tumor angiogenesisInternational Journal of Pharmaceutics, 2023
- Periodic mesoporous ionosilica nanoparticles for dual cancer therapy: Two-photon excitation siRNA gene silencing in cells and photodynamic therapy in zebrafish embryosInternational Journal of Pharmaceutics, 2023
- Triphenylphosphonium-functionalized N-heterocyclic carbene platinum complexes [(NHC-TPP+)Pt] induce cell death of human glioblastoma cancer stem cellsInternational Journal of Pharmaceutics, 2023
- Chronic exposure to nitric oxide sensitizes prostate cancer cells and improved ZnO/CisPt NPs cytotoxicity and selectivityInternational Journal of Pharmaceutics, 2023